Ep187: Eric Fischer on Creating a New Class of Medicines
The Long Run with Luke Timmerman ›1:05:48 | Oct 14th
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
1:05:48 | Oct 14th
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations